Worth reading
44Recurring
Scored from 1 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
54000
SharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
Second Stock Acquisition Rights issued through a third-party allotment (with an exercise price adjustment clause)
発行・処分する株式数
Shares delivered since the beginning of the month: 54,000 shares (new shares: 0 shares; transferred treasury shares: 54,000 shares)
Terms of the stock acquisition rights
Exercise price
The filing states that the rights have an exercise price adjustment provision, but the adjustment floor is Not disclosed. The exercise price during the period covered was ¥2,197–¥2,385.
Number of Stock Acquisition Rights
Total issued: 3,800 rights (540 rights exercised, representing 14.21% of the total issued); unexercised at the end of the previous month: 2,760 rights; currently unexercised: 2,220 rights
Most recent equity financing
10 March 2025: Issuance of Series 2 Stock Acquisition Rights through a third-party allotment (issue amount: Not disclosed)
| Item | Details |
|---|---|
| Type of issuance or disposal | Second Stock Acquisition Rights issued through a third-party allotment (with an exercise price adjustment clause) |
| Number of shares to be issued or disposed of | Shares delivered since the beginning of the month: 54,000 shares (new shares: 0 shares; transferred treasury shares: 54,000 shares) |
| Total number of issued shares | 1,789,487 shares (as of the end of the month preceding the target month, including 154,861 treasury shares) → Not disclosed |
| Exercise price | The filing states that the rights have an exercise price adjustment provision, but the adjustment floor is Not disclosed. The exercise price during the period covered was ¥2,197–¥2,385. |
| Number of Stock Acquisition Rights | Total issued: 3,800 rights (540 rights exercised, representing 14.21% of the total issued); unexercised at the end of the previous month: 2,760 rights; currently unexercised: 2,220 rights |
| Most recent equity financing | 10 March 2025: Issuance of Series 2 Stock Acquisition Rights through a third-party allotment (issue amount: Not disclosed) |
Items this document does not state (22)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allotteeIntended allottee's holding policyDilution RateBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioProcedures under the Corporate Code of ConductMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The company stated that the purpose was to report the monthly exercise status of the bulk exercise of Series 2 Stock Acquisition Rights during the period from 1 September 2026 to 29 September 2026.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.